192 related articles for article (PubMed ID: 29296081)
1. Effect of dacarbazine on CD44 in live melanoma cells as measured by atomic force microscopy-based nanoscopy.
Huang X; He J; Zhang HT; Sun K; Yang J; Wang H; Zhang H; Guo Z; Zha ZG; Zhou C
Int J Nanomedicine; 2017; 12():8867-8886. PubMed ID: 29296081
[TBL] [Abstract][Full Text] [Related]
2. Molecular weight specific impact of soluble and immobilized hyaluronan on CD44 expressing melanoma cells in 3D collagen matrices.
Sapudom J; Ullm F; Martin S; Kalbitzer L; Naab J; Möller S; Schnabelrauch M; Anderegg U; Schmidt S; Pompe T
Acta Biomater; 2017 Mar; 50():259-270. PubMed ID: 27965172
[TBL] [Abstract][Full Text] [Related]
3. Effect of dacarbazine (DTIC) on cultures from malignant melanoma of the choroid: an immunohistochemical and electron microscopic study.
Sivkova N; Steuhl KP; Rohrbach J; Popova L
Folia Med (Plovdiv); 1999; 41(3):5-11. PubMed ID: 10658360
[TBL] [Abstract][Full Text] [Related]
4. Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
Hardy KM; Strizzi L; Margaryan NV; Gupta K; Murphy GF; Scolyer RA; Hendrix MJ
Mol Cancer Res; 2015 Apr; 13(4):670-80. PubMed ID: 25767211
[TBL] [Abstract][Full Text] [Related]
5. An easy method to detect the kinetics of CD44 antibody and its receptors on B16 cells using atomic force microscopy.
Jin H; Zhao H; Chen X; Ma L; Huang X; Ye H; Cai J
Mol Biol Rep; 2011 Oct; 38(7):4495-500. PubMed ID: 21140224
[TBL] [Abstract][Full Text] [Related]
6. Dacarbazine inhibits proliferation of melanoma FEMX-1 cells by up-regulating expression of miRNA-200.
Chen YN
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1191-1197. PubMed ID: 28387914
[TBL] [Abstract][Full Text] [Related]
7. DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.
Ding B; Zhang W; Wu X; Wang J; Xie C; Huang X; Zhan S; Zheng Y; Huang Y; Xu N; Ding X; Gao S
Oncotarget; 2016 Aug; 7(35):57160-57170. PubMed ID: 27494835
[TBL] [Abstract][Full Text] [Related]
8. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity.
Ding B; Wu X; Fan W; Wu Z; Gao J; Zhang W; Ma L; Xiang W; Zhu Q; Liu J; Ding X; Gao S
Int J Nanomedicine; 2011; 6():1991-2005. PubMed ID: 21976975
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
Lillehammer T; Engesaeter BO; Prasmickaite L; Maelandsmo GM; Fodstad O; Engebraaten O
J Gene Med; 2007 Jun; 9(6):440-51. PubMed ID: 17410615
[TBL] [Abstract][Full Text] [Related]
10. Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells.
Risberg K; Fodstad O; Andersson Y
J Immunother; 2010 Apr; 33(3):272-8. PubMed ID: 20445347
[TBL] [Abstract][Full Text] [Related]
11. The curcumin analog DM-1 induces apoptotic cell death in melanoma.
Faião-Flores F; Suarez JA; Maria-Engler SS; Soto-Cerrato V; Pérez-Tomás R; Maria DA
Tumour Biol; 2013 Apr; 34(2):1119-29. PubMed ID: 23359272
[TBL] [Abstract][Full Text] [Related]
12. Tyrosinase overexpression promotes ATM-dependent p53 phosphorylation by quercetin and sensitizes melanoma cells to dacarbazine.
Thangasamy T; Sittadjody S; Limesand KH; Burd R
Cell Oncol; 2008; 30(5):371-87. PubMed ID: 18791269
[TBL] [Abstract][Full Text] [Related]
13. Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
Lev DC; Ruiz M; Mills L; McGary EC; Price JE; Bar-Eli M
Mol Cancer Ther; 2003 Aug; 2(8):753-63. PubMed ID: 12939465
[TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo inhibition of melanoma growth and metastasis by the drug combination of celecoxib and dacarbazine.
Sadhu SS; Wang S; Averineni RK; Seefeldt T; Yang Y; Guan X
Melanoma Res; 2016 Dec; 26(6):572-579. PubMed ID: 27540834
[TBL] [Abstract][Full Text] [Related]
15. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
Yang S; Haluska FG
J Immunol; 2004 Apr; 172(7):4599-608. PubMed ID: 15034078
[TBL] [Abstract][Full Text] [Related]
16. [Determination of dacarbazine in the urine of mice with melanoma by high performance liquid chromatography].
Yue Y; Zhou B; Ai J; Feng S
Se Pu; 2020 Nov; 38(11):1302-1307. PubMed ID: 34213101
[TBL] [Abstract][Full Text] [Related]
17. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Serrone L; Zeuli M; Sega FM; Cognetti F
J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
[TBL] [Abstract][Full Text] [Related]
18. Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells.
Pei J; Su Z; Zeng X; Zhong Y; Zhang Y; Yang Y; Lu Q; Li J; Deng Y
BMC Complement Med Ther; 2023 Apr; 23(1):111. PubMed ID: 37024907
[TBL] [Abstract][Full Text] [Related]
19. B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment.
Olszewska-Słonina DM; Styczyńisk J; Drewa TA; Olszewski KJ; Czajkowski R
Acta Pol Pharm; 2005; 62(6):473-83. PubMed ID: 16583988
[TBL] [Abstract][Full Text] [Related]
20. Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea.
Philip PA; Souliotis VL; Harris AL; Salisbury A; Tates AD; Mitchell K; van Delft JH; Ganesan TS; Kyrtopoulos SA
Clin Cancer Res; 1996 Feb; 2(2):303-10. PubMed ID: 9816173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]